Russell Silver
Physical Medicine & Rehabilitation · New York, NYNPI 1053377796
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,260 of the $34,326 with a category attached, or 79.4%. Amgen accounts for 67.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $24,848 and has fallen 99.9% since, to $31 in 2025. Among physical medicine & rehabilitation clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $83.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$23K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$7K
- Redhill Biopharma Inc.$901
- Scilex Pharmaceuticals Inc.$781
- Daiichi Sankyo Inc.$596
- Pfizer$392
- plus $1K from 10 others
What the payments were for
- Consulting fees$8302%
- Speaking & faculty fees$27,26079%
- Travel & lodging$6982%
- Food & beverage$5,53716%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 47 | $23,015 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 124 | $7,309 |
| Redhill Biopharma Inc. | 5 | $901 |
| Scilex Pharmaceuticals Inc. | 75 | $781 |
| Daiichi Sankyo Inc. | 62 | $596 |
| Pfizer | 25 | $392 |
| Collegium Pharmaceutical, Inc. | 19 | $263 |
| Fidia Pharma USA Inc. | 16 | $192 |
| Curonix LLC | 2 | $164 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $157 |
| Forte Bio-pharma LLC | 7 | $157 |
| Assertio Therapeutics, Inc. | 7 | $141 |
| Johnson & Johnson | 5 | $108 |
| Almatica Pharma LLC | 4 | $99 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RAYOS$68,064
- RELISTOR$5,493
- MOVANTIK$830
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$143
How this compares
$34,326 in reported general payments places this provider in the 95th percentile of 872 physical medicine & rehabilitation providers in New York.
See all physical medicine & rehabilitation providers in New York →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 13 | $29,688 |
| Diclofenac Sodium | 66 | $14,820 |
| MounjaroTirzepatide | 14 | $13,237 |
| OzempicSemaglutide | 14 | $13,025 |
| OxycontinOxycodone Hcl | 12 | $10,852 |
| MovantikNaloxegol Oxalate | 16 | $10,697 |
| Chlorzoxazone | 35 | $10,324 |
| Fentanyl | 14 | $7,496 |
| Lidocaine | 44 | $3,070 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 103 | $3,019 |
| Oxycodone Hcl | 58 | $3,007 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $1,008 |
| Naloxone Hcl | 12 | $730 |
| Meloxicam | 87 | $350 |
| Tramadol Hcl | 31 | $343 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $7,309 | $29,68813 claims |
| Redhill Biopharma Inc.Movantik | $901 | $10,69716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 872 physical medicine & rehabilitation providers in New York.
Other physical medicine & rehabilitation in New York
- Heidi FuscoNew York$153K
- Michael OdellNew York$67K
- Craig AntellNew York$65K
- Michael StubblefieldNew York$53K
- Heakyung KimNew York$53K
- Julia IafrateNew York$32K
- Neil JaseyNew York$29K
- Christian CustodioNew York$19K
- Karan JoharNew York$14K
- Samantha ErosaNew York$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.